Silicon Valley Innovations (SVI) brings 30+ years of MedTech experience to the future of Respiratory Health & ENT. SVI’s breakthrough technologies span the patient care continuum - beginning with the company’s flagship product NasoClenz - the first comfortable, convenient, and effective way to optimize nasal function. SVI’s patent portfolio includes OTC products & novel devices for respiratory health, intranasal delivery of therapeutic medications & intranasal delivery of vaccines.